Search for: "State v. Bristol-Myers Squibb Co." Results 141 - 160 of 189
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Feb 2011, 11:47 am by Sheppard Mullin
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
19 Jun 2017, 12:47 pm by Mark Walsh
Before we can even finish pondering that, Alito is on to his second case, Bristol-Myers Squibb Co. v. [read post]
28 Nov 2006, 4:11 pm
Anticipation does not require proof of "utility," or (in other words) "actual performance of suggestions in a disclosure," Bristol-Myers Squibb Co. v. [read post]
20 Jun 2017, 4:29 am by Edith Roberts
And in Bristol-Myers Squibb Co. v. [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
20 Jan 2011, 12:50 pm by Bexis
Bristol-Myers Squibb Co., 353 F.3d 848, 852 (10th Cir. 2003); In re Norplant Contraceptive Products Liability Litigation, 955 F. [read post]
20 May 2022, 10:26 am by Holly Brezee
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]
9 Nov 2022, 1:00 pm by Holly Brezee
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]
24 Jun 2010, 5:00 am by Bexis
Bristol-Myers Squibb Co., 181 F.R.D. 365 (N.D. [read post]
20 Mar 2023, 7:52 am by Rebecca Tushnet
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
2 Nov 2009, 1:24 pm
  At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
5 Jun 2013, 5:29 am by Schachtman
Bristol-Myers Squibb, 97 F. [read post]